Publications
Detailed Information
Hepatitis A: Clinical Manifestations and Management
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeong, Sook-Hyang | - |
dc.contributor.author | Lee, Hyo-Suk | - |
dc.date.accessioned | 2012-05-29T06:20:33Z | - |
dc.date.available | 2012-05-29T06:20:33Z | - |
dc.date.issued | 2010 | - |
dc.identifier.citation | INTERVIROLOGY; Vol.53 1; 15-19 | ko_KR |
dc.identifier.issn | 0300-5526 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76549 | - |
dc.description.abstract | Due to improved living conditions and subsequent changes in hepatitis A epidemiology, the disease burden of hepatitis A is increasing in many regions. Recently, Korea has faced a large, community-wide outbreak of hepatitis A, which has prompted a vaccination program. The clinical spectrum of hepatitis A virus infection ranges from asymptomatic infection to fulminant hepatitis. Clinical manifestations depend on the age of the host: less than 30% of infected young children are symptomatic, while about 80% of infected adults manifest severe hepatitis with remarkably elevated serum aminotransferases. Fulminant hepatitis is rare, with a reported incidence from 0.015 to 0.5%. Atypical manifestations include relapsing hepatitis and prolonged cholestasis, and complicated cases with acute kidney injury have been reported. Extrahepatic manifestations, such as autoimmune hemolytic anemia, aplastic anemia, pure red cell aplasia, pleural or pericardial effusion, acute reactive arthritis, acute pancreatitis, acalculous cholecystitis, mononeuritis, and Guillain-Barre syndrome, have been rarely reported. Management of hepatitis A includes general supportive care, and critical decisions regarding liver transplantation await further studies on prognostic predictors. Fundamental management of hepatitis A is active vaccination. However, a vaccination program should be adapted to the regional situation, according to differing epidemiology and disease burden. Copyright (C) 2010 S. Karger AG, Basel | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | KARGER | ko_KR |
dc.subject | Clinical manifestation | ko_KR |
dc.subject | Prognosis | ko_KR |
dc.subject | Management | ko_KR |
dc.subject | Hepatitis A virus | ko_KR |
dc.subject | Korea | ko_KR |
dc.title | Hepatitis A: Clinical Manifestations and Management | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 정숙향 | - |
dc.contributor.AlternativeAuthor | 이효석 | - |
dc.identifier.doi | 10.1159/000252779 | - |
dc.citation.journaltitle | INTERVIROLOGY | - |
dc.description.citedreference | Kim HW, 2008, NEPHROLOGY, V13, P451, DOI 10.1111/j.1440-1797.2008.00974.x | - |
dc.description.citedreference | Hussain Z, 2008, DIGEST DIS SCI, V53, P506, DOI 10.1007/s10620-007-9870-9 | - |
dc.description.citedreference | Lee D, 2008, INTERVIROLOGY, V51, P70, DOI 10.1159/000127428 | - |
dc.description.citedreference | KIM JM, 2008, KOREAN J HEPATOL, V14, P474 | - |
dc.description.citedreference | JEONG SH, 2008, KOREAN J GASTROENTER, V51, P331 | - |
dc.description.citedreference | Victor JC, 2007, NEW ENGL J MED, V357, P1685, DOI 10.1056/NEJMoa070546 | - |
dc.description.citedreference | Orr N, 2006, VACCINE, V24, P4328, DOI 10.1016/j.vaccine.2006.03.010 | - |
dc.description.citedreference | Elinav E, 2006, GASTROENTEROLOGY, V130, P1129, DOI 10.1053/j.gastro.2006.01.007 | - |
dc.description.citedreference | Martin A, 2006, HEPATOLOGY, V43, pS164, DOI 10.1002/hep.21052 | - |
dc.description.citedreference | Nainan OV, 2006, CLIN MICROBIOL REV, V19, P63, DOI 10.1128/CMR.19.1.63-79.2006 | - |
dc.description.citedreference | Eisenbach C, 2006, J CLIN VIROL, V35, P109, DOI 10.1016/j.jcv.2005.08.005 | - |
dc.description.citedreference | Wheeler C, 2005, NEW ENGL J MED, V353, P890, DOI 10.1056/NEJMoa050855 | - |
dc.description.citedreference | Wasley A, 2005, JAMA-J AM MED ASSOC, V294, P194 | - |
dc.description.citedreference | Jacobsen KH, 2004, EPIDEMIOL INFECT, V132, P1005, DOI 10.1017/S0950268804002857 | - |
dc.description.citedreference | Rezende G, 2003, HEPATOLOGY, V38, P613, DOI 10.1053/jhep.2003.50366 | - |
dc.description.citedreference | Sagnelli E, 2003, J MED VIROL, V71, P1, DOI 10.1002/jmv.10455 | - |
dc.description.citedreference | Almasio PL, 2003, VACCINE, V21, P2238, DOI 10.1016/S0264-410X(03)00139-7 | - |
dc.description.citedreference | Fujiwara K, 2002, GUT, V51, P82 | - |
dc.description.citedreference | Abid S, 2002, AM J GASTROENTEROL, V97, P1544 | - |
dc.description.citedreference | BELL BP, 2002, SEMIN PEDIAT INFECT, V13, P165 | - |
dc.description.citedreference | Cuthbert JA, 2001, CLIN MICROBIOL REV, V14, P38 | - |
dc.description.citedreference | Staes CJ, 2000, PEDIATRICS, V106, part. no. | - |
dc.description.citedreference | COOKSLEY WG, 2000, J VIRAL HEPAT S1, V7, P29 | - |
dc.description.citedreference | Grinde B, 1997, J MED VIROL, V53, P69 | - |
dc.description.citedreference | TONG MJ, 1995, J INFECT DIS, V171, pS15 | - |
dc.description.tc | 10 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.